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SUMMARY
Objectives: To evaluate the cost-effectiveness of changing open-
ing times, introducing a donor health report and reducing the
minimum inter-donation interval for donors attending static
centres.
Background: Evidence is required about the effect of changes
to the blood collection service on costs and the frequency of
donation.
Methods/Materials: This study estimated the effect of changes
to the blood collection service in England on the annual number
of whole-blood donations by current donors. We used donors’
responses to a stated preference survey, donor registry data
on donation frequency and deferral rates from the INTERVAL
trial. Costs measured were those anticipated to differ between
strategies. We reported the cost per additional unit of blood
collected for each strategy versus current practice. Strategies
with a cost per additional unit of whole blood less than £30 (an
estimate of the current cost of collection) were judged likely to
be cost-effective.
Results: In static donor centres, extending opening times to
evenings and weekends provided an additional unit of whole
blood at a cost of £23 and £29, respectively. Introducing a health
report cost £130 per additional unit of blood collected. Although
the strategy of reducing the minimum inter-donation interval
had the lowest cost per additional unit of blood collected (£10),
this increased the rate of deferrals due to low haemoglobin (Hb).
Conclusion: The introduction of a donor health report is
unlikely to provide a sufficient increase in donation frequency
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to justify the additional costs. A more cost-effective change is to
extend opening hours for blood collection at static centres.
Key words: blood donation, cost-effectiveness analysis, stated
preferences.
The World Health Organisation (WHO) and the International
Federation of Red Cross and Red Crescent Societies (IFRC) set
out a shared global vision for a self-sufficient blood supply by
2020 (WHO and IFRC, 2010). This framework for action called
on blood supply agencies to encourage more frequent donation
from current whole-blood donors, such as by making blood
donation more convenient. However, there is little evidence
about the effect that changes to the blood collection service have
on the frequency and costs of whole-blood donation.
Blood supply agencies require evidence on the relative costs
and effectiveness of alternative strategies, whether they are
required to increase, decrease or maintain the current levels of
whole blood supplied. In England, the overall demand for whole
blood is falling, but there is increased demand for the universal
blood type O negative (O−) as well as A negative (A−), B nega-
tive (B−) and rare blood subtypesmore common in Black, Asian
and minority ethnic (BAME) donors (e.g. Ro). A key challenge
is to identify changes to the blood service that increase donation
frequency for those donors whose blood type is in relatively high
demand at low additional cost.
The Health Economics Modelling of alternative blood
donation strategies (HEMO) study aimed to assess the
cost-effectiveness of strategies to maintain the blood supply
in England (Grieve et al., 2017, in press). The study estimated
the frequency with which existing donors would be willing to
donate whole blood following changes to the current blood
collection service. This paper reports the essential features of
the cost-effectiveness analysis (CEA) and its implications for
policymakers.
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Table 1. Overview of the cost-effectiveness analysis
Strategy Target population Attribute levels with status quo Attribute levels with new strategy
Provision of health report for all
donors
All donors who gave blood in last
year.
Health report not provided Health report provided
Weekend opening at static donor
centres
All donors who gave blood in the
last year at a static donor centre
that is not routinely open at
weekends.
Appointment availability
Every weekday Monday–Friday
Every day: Monday–Sunday
Weekday evening opening at
static donor centres
All donors who gave blood in the
last year at a static donor centre
that did not remain open until
20·00 on weekdays.
Current opening hours Opening hours 09·00–20·00
Weekend opening of mobile
sessions
All donors who gave blood in the
last year at a mobile session
that is not routinely open at
weekends.
Appointment availability
1 day every 2months:
Monday–Friday
Appointment availability
1 day every 2months: Saturday or
Sunday
Weekday evening opening of
mobile sessions
All donors who gave blood in the
last year at a mobile sessions
that is not routinely open until
20·00 on weekdays.
Current opening hours Opening hours 14·00–20·00
Shorter minimum interval
between donations for both
men and women
All donors who gave blood in the
last year at a static donor
centre.
Maximum number of donations:
Males four times per year and
Females three times per year
Maximum number of donations:
Males six times per year;
Females four times per year
MATERIALS AND METHOD
Strategies for the CEA
In England, the NHS Blood and Transplantation (NHSBT)
strategy emphasised the need to improve the donation experi-
ence for existing donors (NHS Blood and Transplant, 2015).The
HEMO study therefore considered alternative service changes
for increasing donation frequency for current whole-blood
donors; strategies to attract new donors were outside the study
scope. The service changes of interest were identified through
a review of NHSBT strategy documents, the results of market
research, an informal review of relevant published literature,
consultation with policymakers and insights from preliminary
qualitative research with donors. The six strategies consid-
ered were the provision of a donor health report (at all blood
collection venues), offering weekend and evening donation
opportunities at either static centres or mobile sessions and
reducing the minimum interval between donations for donors
at static centres (see Table 1).
Each strategy involved a single change to the blood collec-
tion service compared to the current service experienced by
whole-blood donors. The strategies are not mutually exclusive
and are not ‘scalable’ to the same degree, so we made a series of
pairwise comparisons for each potential change compared to the
current service provision. A 1-year time horizon was adopted
as the longer-term demand for blood is unknown, and the
shorter-term effects of the alternative strategies on the volume
and type of blood collected were considered more relevant for
future policy.
Health report
Several European blood supply agencies provide informa-
tion about donors’ own health to incentivise blood donation
(Marantidou et al., 2007). A health report provides donors with
information about their own health from data routinely col-
lected during blood donation, and sometimes from additional
tests. The policy is controversial; blood supply agencies are
not providers of healthcare, and evidence of its effectiveness in
increasing the blood supply is mixed (Goette et al., 2009). The
HEMO study defined a health report as information provided
to a donor on their blood pressure taken prior to donation and a
cholesterol test taken from the blood sample after each donation.
The analysis excluded any longer-term sequelae following the
health report.
Session opening times
Holding sessions at evenings and weekends may make blood
donation more convenient and increase donation frequency. To
investigate realistic changes to opening times at static centres, we
assumed that providing sessions at weekends or during week-
day evenings would be additional to those provided during cur-
rent opening hours. For mobile sessions, it was more realistic to
assume that weekend or weekday evening sessions would sub-
stitute daytime sessions. In 2016, 86% of blood donations were
made at a mobile session. In total, 23 000 mobile sessions were
held in England for whole-blood donation, of which only 10 %
were open until 20:00 and only 4 % at weekends. Donors can
also visit 1 of 24 permanent static centres where blood collection
Transfusion Medicine, 2018 © 2018 The Authors.
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is offered in the same venue several days a week. Of the static
donor centres, 15 were routinely open at weekends in 2016, and
5 offered sessions until 20:00 on weekday evenings.
Inter-donation interval
INTERVAL, a large multicentre, randomised, controlled trial,
provided evidence on whether reducing inter-donation inter-
vals in all static centres in England would increase donation fre-
quency without compromising donor safety (Di Angelantonio
et al., 2017; Moore et al. 2014). The trial reported that donors
randomised to the shorter minimum donation interval (8 weeks
for men, 10 weeks for women) successfully donated more whole
blood on average compared to those randomised to the current
minimum donation intervals (12weeks for men, 16weeks for
women). Higher rates of deferral were recorded in the shorter
donation interval randomised arms.
The HEMO study assessed the cost-effectiveness of the short-
est minimum inter-donation interval adopted in the INTERVAL
trial for men and women donating at static donor centres versus
current minimum donation intervals.
Stated preference survey
The CEA required predictions of the effects of alternative
changes to the blood service on the frequency of blood dona-
tion. In England, these potential service changes have either not
been implemented at all (e.g. the donor health report) or have
only been implemented in some venues (e.g. weekend opening).
We therefore needed to understand how donors might respond
to these changes to the service without first experiencing them.
Formal methods to elicit choices under hypothetical conditions,
known as stated preferences, are used extensively in transport,
environmental and health economics when information on
actual choices, known as revealed preferences, are not available.
We conducted a large stated preference survey of donors who
had donated whole blood at least once in the previous year.
The stated preference survey was designed iteratively, incor-
porating the views of NHSBT policymakers and donors. The
survey was revised following a large pilot study (De Corte et al.,
2016). The final survey included five attributes that described
those characteristics of the blood service that were liable to be
modified following proposed changes to the blood service. The
chosen attributes were: donor travel time to the blood donation
venue; the opening hours for blood collection; and the availabil-
ity of appointments for blood donation, provision of a health
report and the maximum number of whole-blood donations
permitted in a year. For each attribute, alternative levels were
defined according to current and future service provision; e.g.
for the health report attribute, two levels were defined according
to whether or not a health report was provided.
Figure 1 presents an example question from the survey.
Respondents were asked to state the frequency with which
they would be willing to donate blood according to the
Fig. 1. An example of a question from the stated preference survey.
© 2018 The Authors. Transfusion Medicine, 2018
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Table 2. Background characteristics of the population and respondents to the stated preference survey
Donors who responded to
the survey (N = 23 981)
All donors in March 2016 extract
of PULSE database (N = 781 028)
who had donated in the last 12months
N % N %
Age group 17–30 3 309 13·80 188 744 24·17
31–45 5 774 24·08 205 505 26·31
46–60 9 824 40·97 267 856 34·30
60+ 5 073 21·15 118 923 15·23
Blood type High demand 2 472 10·31 111 948 14·33
Standard demand 21 509 89·69 669 080 85·67
Ethnicity White 22 339 93·15 724 880 92·81
Black/mixed Black 201 0·84 8 315 1·06
Asian/mixed Asian 562 2·34 21 727 2·78
Other or not stated 879 3·67 26 106 3·34
‘Nursery’ donor Yes 6 566 27·38 283 502 36·30
No 17 415 72·62 497 526 63·70
Session type Static centre 2 053 8·53 107 811 13·80
Mobile session1 21 928 91·44 673 217 86·20
Number of donations in last 12months 1 7 148 29·81 317 266 40·62
2 8 063 33·62 245 984 31·49
3 7 267 30·30 183 211 23·46
4 1 454 6·06 29 460 3·77
5 40 0·17 3 450 0·44
6 9 0·04 1 657 0·21
1A session is an organisational feature of NHSBT that can be understood as a single effort to collect blood on one particular day, by a particular team,
in a particular location. For example, even if the same team collects blood at the same location for two consecutive days, this would be considered two
sessions.
alternative attributes and levels offered in different scenarios.
We hypothesised that donors would state a higher frequency
of donation if they were offered an incentive to donate, such
as a health report, or if donation was made more convenient,
e.g. by providing opportunities to donate at weekends or in the
evening.
The survey received ethical approval from both NHS (ref-
erence 16/YH/0023) and LSHTM (reference 10 384) Research
Ethics Committees. A total of 100 000 donors were randomly
selected to be sent an email inviting them to take part in
the online survey if they met the following inclusion criteria:
17–70 years old, donation of at least one unit of whole blood in
the past 12months, email address held by NHSBT and residence
in mainland England. Donors were excluded if they had been
temporarily suspended from donating (e.g. if they had recently
had a tattoo) and if they had recently taken part in a routine sur-
vey or research study.
A total of 25 187 donors responded to the survey (25·2%).The
donors who responded to the survey were somewhat different
to the overall target population (Table 2), e.g. the proportion of
donors over 60 years old was higher for the survey responders
than the overall target population (21% vs 15%).
Target population
The overall target population was all whole-blood donors
who had successfully given blood at least once in the year
prior to March 2016 and who resided in mainland England
(N = 781 028) (see Table 2). Although all donors were eligible
for a health report after each donation, for the strategies that
involved changes to opening times of the blood collection
venues, the target population was limited to donors who last
gave blood at a venue that was not already open at weekends and
evenings. The target population for the strategy to reduce the
minimum inter-donation interval was limited to those donors
whose last blood donation was at a static donor centre.
Predicting total volume of blood
The responses to the stated preference survey were used to pre-
dict the average number of whole-blood donations per year fol-
lowing the alternative changes to the blood service defined by
each strategy. A major assumption is that individuals’ responses
to survey questions will predict their actual behaviour.We inves-
tigated whether this assumption was plausible and found that,
on average, there was a small discrepancy between the donation
frequency predicted from the survey responses and the actual
donation frequency observed in the PULSE donor register (De
Corte et al., 2016; Grieve et al., 2017, in press).
The data from the response to the survey were analysed to
estimate the effect of potential service changes on the annual
frequency of whole-blood donation. As the response data were
categorical and naturally ordered, an ordered logit model was
Transfusion Medicine, 2018 © 2018 The Authors.
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chosen and included attributes from the stated preference survey
as independent (exposure) variables (Greene, 2017). To allow
for differences in observed characteristics between the survey
responders and the overall target population, the model also
included each of the characteristics listed in Table 2 as indepen-
dent variables.
Adjusting for deferred donations
If a donor’s haemoglobin (Hb) levels are below 135 g L−1 for
males or 125 g L−1 for females, blood collection NHSBT policy
is that donation will be temporarily suspended, or deferred, for
at least 6months (or longer if Hb is particularly low). Donations
can also be deferred due to other reasons, e.g. related to travel,
medication, lifestyle or infection/illness. The INTERVAL trial
reported that deferrals due to lowHbwere higher for the patients
randomised to reduced minimum interval (Di Angelantonio
et al., 2017). We used estimates from applying a logistic regres-
sion model to the trial data, which estimated the effect of chang-
ing the minimum interval on deferral rates and allowed for
patient characteristics, to predict deferral rates per attendance
according to the levels of those characteristics in the target
population.
Difference in volume of blood collected between strategies
The incremental effect of each strategy was calculated as the
difference between the predicted mean volumes of blood before
and after the proposed service change. The number of annual
blood donation visits was calculated for each donor in the target
population according to the donor’s personal characteristics and
the service-level attributes that defined each donor’s most recent
experience of giving blood. We predicted the number of blood
donation visits by combining the estimated coefficients from
the ordered logit model applied to the survey response data
with the characteristics of each donor in the target population.
The predicted annual frequency of donation allowed for the
estimated probability of deferral. The predicted annual mean
number of units of blood donated per donor was thenmultiplied
by the number of donors in the target population to calculate the
annual total volume of blood collected across the service. Finally,
the predictions were repeated after changing the attribute level
associated with each proposed service change (see Table 1).
Costs
Cost measurement was from the NHS and personal social
services perspective recommended by NICE (NICE methods
guide, 2013). The costs included were those anticipated to dif-
fer between strategies, including additional collection and staff
costs but not processing, marketing or fixed costs. Costs beyond
1 year were not considered. Three types of cost were included:
the variable cost of collecting blood associatedwith each strategy
(staff costs including unsocial hours premium, invitations, con-
sumables), the costs of providing a health report, and the cost of
deferrals.
Variable cost of blood collection
The variable costs covered the cost of inviting donors, staff time
anddisposables.We assumed that processing costswere constant
across strategies and that the service was scalable to any volume
of blood collected.The cost measurement recognised differences
in unit costs between mobile sessions and static donor centres
and that, on average, mobile sessions were close to capacity
(95%), whereas static centres were not (75%). The base case
analysis therefore assumed that strategies which required more
blood to be collected would require additional staff at mobile
sessions but not in static centres, where additional collection
within current opening times would be undertaken by existing
staff. In both settings, the costs of staff employed atweekends and
during evenings were calculated at appropriate additional rates
(The NHS Staff Council, 2016).
Costs of providing a health report
The health report costs assumed that the cholesterol test would
be undertaken alongside others routinely undertaken at small
additional cost (Czoski-Murray et al. 2012; Department of
Health 2008). We assumed that to measure blood pressure
required an additional 1·5min per donor. We assumed that 2 %
of tests would require a letter to advise clinical follow up.
Cost of deferrals
The cost of deferrals included the time taken for donor carers to
undertake a health screen and, where deferral was due to lowHb,
a copper sulphate and HemoCue® test (HemoCue®, Radiome-
ter Medical ApS, Denmark). We assumed based on the INTER-
VAL trial data that 7% of these donors would be referred to their
Primary Care Physician (when Hb is less than 125 g L−1 for men
and 115 g L−1 for women) and then that healthcare costs would
be incurred. These costs were assumed to include a GP appoint-
ment, a full blood count test and Serum ferritin test, iron sup-
plements (50% of donors) and an outpatient appointment (10%
donors). The accompanying unit costs were taken from pub-
lished sources. (Curtis and Burns, 2016; Department of Health,
2016; Health-Care Medical Equipment Group 2017; Joint For-
mulary Committee 2016; National Institute for Health and Care
Excellence, 2015)
Cost-effectiveness analysis
The incremental cost per donor for each strategy compared to
the status quo was calculated as an additional (difference in
means) cost of collecting the additional (difference in means)
volume of blood after the service change.We estimated the incre-
mental cost per additional unit of whole blood collected overall
and for subgroups of prime interest. These include five donor
characteristics: age (17–30, 31–45, 46–60, 60 or over), high or
standard demand blood types, ethnicity (White, Black/mixed
Black, Asian/mixed Asian or Other/not stated), ‘nursery’ donor
© 2018 The Authors. Transfusion Medicine, 2018
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status (fewer than four lifetime donations) and the venue (static
or mobile).
Interpretation of the threshold
The threshold at which the health service in England is willing
to pay to collect an extra unit of blood is unknown. The cost
of a unit of blood for the NHS is around £120, half of which
arises from the costs of collection, which differ across settings.
For example, in England, the collection cost at a mobile session
ranged from £23 to £60 per unit of whole blood (2015–2016),
and sessions with relatively high cost per unit have since been
closed.This implies that, in England, the willingness to pay for a
unit of blood is likely to be around £30–£50, which we used to
interpret our CEA.
Sensitivity analysis
The cost-effectiveness model was probabilistic; the uncertainty
in the estimated incremental costs reflected the uncertainty
in the volume of blood collected and associated resource use
but not in the unit costs that were assumed fixed. We con-
sidered two sources of structural uncertainty: (i) the assump-
tion about current operating capacity and (ii) the statistical
model used to predict volume of blood. We recognised that
static donor centres could require additional staff time to col-
lect extra units of blood, and this increased the unit cost to
£26·49 (£9·41 in the base case).This sensitivity analysis is not rel-
evant for strategies two and three where additional staff costs are
already included in the base case as these strategies represent the
extension of current opening hours. We also considered alter-
native predictive models using a two-part model and gamma
model, rather than the ordered logit model used in the base case
analysis.
RESULTS
The effect of each change to the blood service on the aver-
age number of whole-blood donations per donor per year are
reported in Table 3 for each target population. The results show
that donors would be willing to donate whole blood more
frequently following each of the service changes. The largest
predicted increase in average annual donation frequency was
following strategies to reduce the minimum inter-donation
interval and to introduce weekend opening at static centres
(annual increases of 0·71 and 0·49 donations per donor, respec-
tively). Introducing a health report and providing mobile ses-
sions in the evenings led to small increases in predicted donation
frequency (0·1 and 0·03 per donor per year, respectively).
For each strategy compared to current practice, we report the
incremental (difference in means) volume of blood collected,
incremental costs and incremental cost per additional unit of
blood for the relevant target population (Table 4). Although
each service change was predicted to lead to additional dona-
tions of whole blood, this also led to additional costs, with
the incremental cost per donor per year ranging from £3·16 to
£18·12. These additional costs were for the variable cost of col-
lecting the additional blood yield per donor. Aside from the
introduction of the health report, these higher average costs were
almost exclusively for the costs of collection per se.
Table 4 ranks the strategies in order of their cost-effectiveness.
The strategy to reduce the minimum donation interval was
predicted to provide additional units of whole blood at the
lowest additional cost per unit, followed by the strategies of
extending opening times for blood collection at static centres.
The strategy to substitute mobile weekday sessions with sessions
held at weekends had the lowest additional cost (£3·16) but the
smallest predicted increase in blood donation, and was unlikely
to be cost-effective. At a cost of £136 per additional unit of blood,
the introduction of the health report was very unlikely to be
cost-effective.
The main subgroup analysis was for donors with
‘high-demand’ blood types and is reported in Table 5. The
results were broadly similar in that the strategies with rela-
tively low costs per additional unit of blood donated were the
reduction of the minimum inter-donation interval or weekend
or evening opening for collection in static centres. The results
of the other subgroup analyses revealed some differences in
relative preferences for alternative service changes according
to donors’ characteristics; in particular, donors of Black, mixed
Black, Asian and mixed Asian ethnicities were predicted to
donate more frequently than donors of other ethnicities when
offered the health report. However, the additional costs of
the health report were such that the cost per additional unit
of blood donated remained relatively high for this strategy
(on average, £69 for Black/mixed Black donors and £102 for
Asian/mixed Asian donors, compared to £136 for all donors).
The cost-effectiveness results of other strategies were very
similar across all the subgroups considered.
In the scenario where staff costs were included in the vari-
able cost per unit of blood for strategies one and six, the cost
per additional unit of blood for these strategies increased to £27
(reduced interval) and £139 (health report). In this scenario,
evening opening hours at donor centres was ranked the most
cost-effective strategy at £23 per additional unit of blood col-
lected. When other analytical models were used for the analysis
of the survey data, the ranking of strategies did not change com-
pared to the base case.
DISCUSSION
This analysis found that strategies that improve donation oppor-
tunities at static donor centres offered better value for money
than the introduction of the health report or movingmobile ses-
sions to weekends or evenings.The cost of opening static centres
on weekday evenings or at weekends fell below £30 per addi-
tional unit of blood collected. These results were robust to the
choice of model used to predict donation frequencies from the
survey data and were similar across donor subgroups, includ-
ing the subgroup of prime policy interest, those donors with
Transfusion Medicine, 2018 © 2018 The Authors.
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Table 3. Predicted deferral rates and adjusted annual donation frequency
Strategy
Average annual
visits predicted
per donor
Average annual
number of low
Hb deferrals
per donor
Average annual
number of other
deferrals per
donor
Deferral-adjusted
number donations
per donor
Health report Status quo1 2·595 0·092 0·151 2·362
With health report 2·704 0·096 0·157 2·462
Difference 0·109 0·004 0·006 0·100
Weekend opening of static centres Status quo 2·604 0·092 0·150 2·374
With weekend opening 3·142 0·112 0·181 2·864
Difference 0·538 0·019 0·031 0·489
Evening opening of static centres Status quo 2·779 0·099 0·160 2·534
With evening opening 3·229 0·115 0·185 2·942
Difference 0·45 0·016 0·026 0·408
Weekend opening of mobile sessions Status quo 2·564 0·091 0·149 2·333
With weekend opening 2·599 0·092 0·151 2·363
Difference 0·035 0·001 0·002 0·03
Evening opening of mobile sessions Status quo 2·518 0·089 0·146 2·291
With evening opening 2·744 0·097 0·160 2·49
Difference 0·226 0·008 0·013 0·199
Reduce minimum inter-donation
interval at static centres
Status quo 2·804 0·100 0·161 2·557
Shorter inter-donation interval 3·586 0·128 0·206 3·271
Difference 0·782 0·028 0·045 0·714
1Status quo refers to current blood service provision. The average annual visits predicted differs for the status quo comparator across the strategies
because the relevant target population is not the same, as detailed in Table 1.
Table 4. Incremental cost-effectiveness of each strategy compared to the current blood service provision (mean values across 10 000 simulations)
Strategy
Number of
donors affected
Incremental blood
yield, units all
blood types
(nearest thousand)
Incremental volume
of blood per donor
per year, units
of blood
Incremental
cost, £ GBP
Incremental
cost per additional
unit of blood, £ GBP
Reduce minimum donation interval 107 811 73 000 0·678 6·71 10
Evening opening of static donor centres 99 312 45 000 0·455 10·46 23
Weekend opening of static donor centres 60 640 31 000 0·519 15·21 29
Evening opening of mobile sessions 582 910 282 000 0·484 18·12 37
Weekend opening of mobile sessions 646 898 45 000 0·07 3·16 45
Health report 781 028 88 000 0·113 15·33 136
‘high-demand’ blood types. These findings directly relate to the
blood service in England and other public-funded blood services
required to increase the volume of particular types of blood and
add to the limited literature on the cost-effectiveness of alter-
native changes to a blood collection service (Van Der Pol &
Cairns, 1998; Van Der Pol et al., 2000; Varney & Guest, 2003;
Dixon et al., 2005; Pereira, 2006; Rautonen, 2007; Katsaliaki,
2008; Lowalekar & Ravichandran, 2010; Abraham & Sunday,
2012; Beliën & Forcé, 2012; Williamson & Devine, 2013).
Reducing the minimum interval between donations at
static donor centre was the most cost-effective strategy at £10
per additional unit of blood collected, but concerns remain
about ‘rolling out’ a strategy of reducing the minimum inter-
val for all donors. The INTERVAL trial reported lower levels
of Hb for some donors over the 2-year follow-up period (Di
Angelantonio et al., 2017). Although our analysis did include the
short-term costs related to Hb deferral, the longer-term impact
of more Hb-related deferrals on donor retention, and hence the
long-term cost-effectiveness of this strategy, is unknown. The
next most cost-effective strategies, the opening of donor centres
at weekends and evenings, may therefore make more efficient
use of scare blood service resources, particularly if there is little
capacity within the system to collect additional units of blood.
Not all strategies are scalable to the same degree. Strate-
gies to improve opportunities to give blood for donors at static
centres could yield between 60 000 and 100 000 units. To sup-
port the collection of additional blood in this quantity, staff
© 2018 The Authors. Transfusion Medicine, 2018
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Table 5. Base case results for donors with ‘high-demand’ blood types
Strategy
Annual cost
per donor
(£GBP)
Total annual
cost (all donors),
000 s (£GBP)
Total units
(all) blood
collected, 000 s
Incremental cost
per additional
unit blood (£GBP)
Health report Status quo 21·57 2414 264 NA
With health report 36·83 4123 276 NA
Difference 15·27 1709 11 152
Weekend opening of static centres Status quo 23·34 186 19 NA
With weekend opening 37·63 300 23 NA
Difference 14·29 114 4 29
Evening opening of static centres Status quo 24·91 321 33 NA
With evening opening 34·25 441 38 NA
Difference 9·34 120 5 23
Weekend opening of mobile sessions Status quo 21·02 1981 220 NA
With weekend opening 22·37 2108 223 NA
Difference 1·35 127 3 45
Evening opening of mobile sessions Status quo 20·64 1756 195 NA
With evening opening 28·1 2390 212 NA
Difference 7·46 635 17 37
Reduce minimum inter-donation
interval at static centres
Status quo 25·13 349 35 NA
Shorter inter-donation interval 32·16 446 45 NA
Difference 7·02 98 10 10
NA, not applicable.
would need to be redeployed from other sessions. Alterna-
tively, the strategies could be implemented so that collection of
high-demand blood types is substituted for other blood types.
If the extra collection of blood was limited to donors with
high-demand blood types, this would imply around 10 000 addi-
tional units of whole blood collected – which is much feasible
within current staffing constraints. The results from our survey
suggest that donors’ preferences would be to donate these addi-
tional units of blood at more convenient times, namely, during
the evenings and at weekends, which would also be relatively
cost-effective.
This analysis suffered from three main limitations. Firstly,
despite the relatively high response rate for an online survey
of the public, it is unclear whether the preferences of our sur-
vey responders are representative of the preferences of all recent
donors. Although the ordered logit model did adjust for dif-
ferences in measured characteristics between the sample and
the target population, there may be differences in unobservable
characteristics between the settings. However, there is no rea-
son to suspect this would bias the CEA in favour of a particular
strategy. Secondly, we did not consider the alternative strategies
to recruit new donors, nor the effect beyond 1 year on the reten-
tion of existing donors.Thirdly, we did not include direct costs to
donors, such as travel expenses. These costs may differ by strat-
egy, but taking a wider societal perspective would also require
that the increased utility for donors from the act of blood dona-
tion itself be included in the analysis.
The findings from the HEMO study are relevant to pub-
licly funded blood supply agencies worldwide as they can be
interpreted according to whether the objective is to increase
or maintain the supply of particular blood types or for whole
blood overall. Although costs and donor preferences are likely
to differ between settings, this paper shows how large-scale sur-
veys of donors’ preferences can generate the required informa-
tion about alternative changes to a blood service to guide future
policy.
Methods to define and analyse the impact of possible changes
to blood collection from a health economic perspective are likely
to become increasingly relevant to blood services faced with
growing pressures. They offer a way forward in the attempt
to balance the sometimes conflicting but insistent demands
of economic efficiency, flexibility to accommodate short- and
medium-term fluctuations in demand and the need to reach dif-
ferent sections of the community.
CONCLUSION
We found that moving mobile sessions to the weekend or pro-
viding health reports did not provide sufficient increases in the
predicted donation frequency to justify the additional costs.
Reducing the minimum inter-donation interval increased vol-
umes of blood donation at low costs in the short term, but
the observed increase in Hb-related deferrals over 2 years, may
imply that this strategy is not cost-effective in the longer term.
Extending the opening hours of static donor centres is in line
with donor preferences and provides a relatively cost-effective
way of providing additional units of blood, particularly blood
types that are in high demand.
Transfusion Medicine, 2018 © 2018 The Authors.
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